MAPT and Alzheimer disease: AD is characterized by amyloid beta (Aβ) plaques due to reduced Aβ clearance or excessive production, and pathological hyperphosphorylated tau aggregates within dendrites and neuronal cell bodies, which together drive progressive synaptic dysfunction, neuronal loss, and cognitive decline [2,3].